BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16129792)

  • 1. Revised Adult Treatment Panel III guidelines and cardiovascular disease mortality in men attending a preventive medical clinic.
    Ardern CI; Katzmarzyk PT; Janssen I; Church TS; Blair SN
    Circulation; 2005 Sep; 112(10):1478-85. PubMed ID: 16129792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men.
    Katzmarzyk PT; Church TS; Blair SN
    Arch Intern Med; 2004 May; 164(10):1092-7. PubMed ID: 15159266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study.
    DECODE Study Group
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):192-9. PubMed ID: 17446796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
    Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium.
    Goff DC; Bertoni AG; Kramer H; Bonds D; Blumenthal RS; Tsai MY; Psaty BM
    Circulation; 2006 Feb; 113(5):647-56. PubMed ID: 16461837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome and mortality: the Singapore Cardiovascular Cohort Study.
    Lee J; Heng D; Ma S; Chew SK; Hughes K; Tai ES
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):225-30. PubMed ID: 18208579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting.
    Mosca L; Merz NB; Blumenthal RS; Cziraky MJ; Fabunmi RP; Sarawate C; Watson KE; Willey VJ; Stanek EJ
    Circulation; 2005 Feb; 111(4):488-93. PubMed ID: 15687138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of pre-disease risk factors within metabolic syndrome on all-cause and cardiovascular disease mortality.
    Tsai SP; Wen CP; Chan HT; Chiang PH; Tsai MK; Cheng TY
    Diabetes Res Clin Pract; 2008 Oct; 82(1):148-56. PubMed ID: 18757109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Cholesterol Education Program Adult Treatment Panel III guidelines and obesity: implications for Canada.
    Ardern CI; Katzmarzyk PT
    Can J Cardiol; 2003 Sep; 19(10):1171-7. PubMed ID: 14532943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
    Persson M; Hedblad B; Nelson JJ; Berglund G
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk factors and metabolic syndrome in alcohol- and nicotine-dependent men and women.
    Jarvis CM; Hayman LL; Braun LT; Schwertz DW; Ferrans CE; Piano MR
    J Cardiovasc Nurs; 2007; 22(6):429-35. PubMed ID: 18090180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
    Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study.
    Sritara P; Patoomanunt P; Woodward M; Narksawat K; Tulyadachanon S; Ratanachaiwong W; Sritara C; Barzi F; Yamwong S; Tanomsup S
    Angiology; 2007 Dec-2008 Jan; 58(6):757-63. PubMed ID: 18216384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of workload at the heart rate of 100 beats/min in predicting cardiovascular mortality in men aged 42, 48, 54, or 60 years at baseline.
    Savonen KP; Lakka TA; Laukkanen JA; Rauramaa TH; Salonen JT; Rauramaa R
    Am J Cardiol; 2007 Aug; 100(4):563-8. PubMed ID: 17697806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome increases all-cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor Study.
    Thomas GN; Schooling CM; McGhee SM; Ho SY; Cheung BM; Wat NM; Janus ED; Lam KS; Lam TH;
    Clin Endocrinol (Oxf); 2007 May; 66(5):666-71. PubMed ID: 17381490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced risk assessment in asymptomatic individuals with exercise testing and Framingham risk scores.
    Mora S; Redberg RF; Sharrett AR; Blumenthal RS
    Circulation; 2005 Sep; 112(11):1566-72. PubMed ID: 16144993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.